VeriSign Investing Cash Flow increased by 72.5% to $187.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 41.1%, from $317.60M to $187.20M. Over 2 years (FY 2021 to FY 2025), Investing Cash Flow shows an upward trend with a -36.3% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $10.30M | -$50.20M | -$54.10M | $524.50M | $54.90M | -$33.40M | $409.80M | -$398.30M | -$213.00M | $496.40M | -$249.90M | $60.50M | $0.00 | $317.60M | -$213.00M | -$104.00M | $108.50M | $187.20M |
| QoQ Change | — | -587.4% | -7.8% | >999% | -89.5% | -160.8% | >999% | -197.2% | +46.5% | +333.1% | -150.3% | +124.2% | -100.0% | — | -167.1% | +51.2% | +204.3% | +72.5% |
| YoY Change | — | — | — | — | +433.0% | +33.5% | -21.9% | -825.5% | -537.7% | +21.1% | +37.3% | +128.4% | — | -36.0% | +14.8% | -271.9% | — | -41.1% |